Adagio Medical (ADGM) Revenue & Revenue Breakdown
Adagio Medical Revenue Highlights
Latest Revenue (Y)
$269.00K
Adagio Medical Revenue by Period
Adagio Medical Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $269.00K | -10.33% |
| 2023-12-31 | $300.00K | 58.73% |
| 2022-12-31 | $189.00K | -30.00% |
| 2021-12-31 | $270.00K | 100.00% |
| 2020-12-31 | - | - |
Adagio Medical generated $269.00K in revenue during NA 2024, up -10.33% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Adagio Medical Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-03-31 | - | -100.00% |
| 2024-12-31 | $-143.00K | -208.33% |
| 2024-09-30 | $132.00K | -48.03% |
| 2024-06-30 | $254.00K | 876.92% |
| 2024-03-31 | $26.00K | -66.67% |
| 2023-12-31 | $78.00K | 90.24% |
| 2023-09-30 | $41.00K | 100.00% |
| 2023-06-30 | - | -100.00% |
| 2023-03-31 | $60.00K | 100.00% |
| 2022-12-31 | - | - |
Adagio Medical generated - in revenue during Q1 2025, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Adagio Medical Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| CASI | CASI Pharmaceuticals | $33.88M | $3.41M |
| NXGL | NEXGEL | $8.69M | $2.88M |
| MGRX | Mangoceuticals | $473.26K | $109.31K |
| COCH | Envoy Medical | $316.00K | $78.00K |
| ADGM | Adagio Medical | $269.00K | - |
| NXL | Nexalin | $168.72K | $41.02K |
| ENTO | Entero Therapeutics | - | - |
| IINN | Inspira Technologies Oxy B.H.N. | - | - |
| MODD | Modular Medical | - | - |
| LPTX | Leap Therapeutics | - | - |
| RNTX | Rein Therapeutics | - | - |